Arcus Biosciences RCUS
NYSE RCUS
$29.58 -0.55 (-1.83%)
As of: Sep 4, 2026 · 2:25 PM EDT

Arcus Biosciences (RCUS) Debt Ratio (2024 - 2026)

Arcus Biosciences (RCUS) posted quarterly Debt Ratio of 0.1 for Q1 2026, up 150.75% year-over-year from 0.04 in Q1 2025, and up 15.4% quarter-over-quarter from 0.09 in Q4 2025.

Analysis

Arcus Biosciences (RCUS) Debt Ratio (2024 - 2026) Analysis & Trends

Arcus Biosciences' Debt Ratio history runs 3 years deep, the most recent figure standing at 0.1 for Q1 2026.

  • In Q1 2026, Debt Ratio rose 150.75% year-over-year to 0.1; the TTM figure through Mar 2026 stood at 0.1 (up 150.75% YoY), while the FY2025 annual figure was 0.09, up 108.24% from the prior year.
  • Debt Ratio for Q1 2026 stood at 0.1, up from 0.09 in the prior quarter.
  • The five-year high for Debt Ratio was 0.1 in Q3 2025, with the low at 0.04 in Q3 2024.
  • The 3-year median for Debt Ratio is 0.09 (2025), against an average of 0.07.
  • Peak annual rise in Debt Ratio reached 178.3% in 2025, while the deepest fall reached 108.24% in 2025.
  • Arcus Biosciences' Debt Ratio stood at 0.04 in 2024, then jumped by 108.24% to 0.09 in 2025, then increased by 15.4% to 0.1 in 2026.
  • Business Quant data shows RCUS's Debt Ratio at 0.1 in Q1 2026, 0.09 in Q4 2025, and 0.1 in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt Ratio (Qtr)
1 Vertex Pharmaceuticals 138.87 Bn 131.01 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.57 Bn 77.57 Bn 3.93 Bn 0.05
3 Argenx Se 63.51 Bn 58.32 Bn 1.37 Bn -
4 Moderna 58.19 Bn 53.05 Bn 52.00 Mn 0.05
5 Revolution Medicines 44.07 Bn 44.07 Bn - -
6 BeOne Medicines 39.99 Bn 34.89 Bn 1.53 Bn 0.12
7 Alnylam Pharmaceuticals 35.38 Bn 32.07 Bn 992.69 Mn -
8 Royalty Pharma 28.42 Bn 27.58 Bn - 0.47
9 Insmed 27.41 Bn 26.25 Bn 358.27 Mn 0.26
10 Arcus Biosciences 3.73 Bn 3.03 Bn - 0.11
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.11
Mar 31, 2026 0.10
Dec 31, 2025 0.09
Sep 30, 2025 0.10
Jun 30, 2025 0.09
Mar 31, 2025 0.04
Dec 31, 2024 0.04
Sep 30, 2024 0.04